Page last updated: 2024-08-24

imiquimod and chitosan

imiquimod has been researched along with chitosan in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (44.44)24.3611
2020's5 (55.56)2.80

Authors

AuthorsStudies
Alonso, MJ; Díaz-Freitas, B; González-Fernández, Á; Peleteiro, M; Sanchez, A; Vicente, S1
Beck, RC; Buffon, A; Chaves, PS; Contri, RV; D'Amore, CM; Frank, AG; Frank, LA; Guterres, SS; Pohlmann, AR1
Adame, S; Adhami, VM; Babatunde, AS; Bharali, DJ; Chamcheu, JC; Esnault, S; Longley, BJ; Massey, RJ; Mousa, SA; Mukhtar, H; Siddiqui, IA; Wood, GS1
Kandimalla, KK; Layek, B; Prabha, S; Rahman Nirzhor, SS; Rathi, S; Wiedmann, TS1
Alvarez-Figueroa, MJ; Armijo-Escalona, N; Carrasco-Flores, EA; González-Aramundiz, JV; Narváez-Araya, D1
Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, SA1
Bai, Y; Fang, X; Fu, B; Huang, H; Li, X; Ma, C; Meng, Z; Miao, W; Qian, C; Ren, H; Tao, X; Wang, A; Yang, Z1
Abourehab, MAS; Hazari, SA; Kesharwani, P; Sheikh, A; Tulbah, AS1
Pu, S; Sun, L; Zhao, K; Zhou, D1

Other Studies

9 other study(ies) available for imiquimod and chitosan

ArticleYear
Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.
    Journal of controlled release : official journal of the Controlled Release Society, 2013, Dec-28, Volume: 172, Issue:3

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cell Line; Chitosan; Complement Activation; Female; Hepatitis B; Hepatitis B Surface Antigens; Imiquimod; Macrophages; Mice; Mice, Inbred BALB C; Nanocapsules; Toll-Like Receptor 7; Vaccination

2013
The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: Increasing penetration and adhesion of imiquimod in vaginal tissue.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017, Volume: 114

    Topics: Administration, Intravaginal; Aminoquinolines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cellulose; Chitosan; Drug Carriers; Drug Compounding; Female; Gels; Humans; Imiquimod; Nanocapsules; Pharmaceutical Vehicles; Polyesters; Swine; Tissue Adhesives; Vagina

2017
Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Antioxidants; Catechin; Cell Differentiation; Cells, Cultured; Chitosan; Dermatitis; Filaggrin Proteins; Humans; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis

2018
Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery.
    AAPS PharmSciTech, 2019, Jan-08, Volume: 20, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Chitosan; Drug Delivery Systems; Drug Design; Drug Liberation; Humans; Imiquimod; Organ Culture Techniques; Skin Absorption

2019
Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy.
    Pharmaceutical research, 2020, Sep-17, Volume: 37, Issue:10

    Topics: Administration, Cutaneous; Animals; Chitosan; Drug Delivery Systems; Fatty Acids; Imiquimod; Nanocapsules; Nonlinear Optical Microscopy; Skin; Skin Absorption; Swine

2020
Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
    Carbohydrate polymers, 2021, Sep-15, Volume: 268

    Topics: Administration, Cutaneous; Animals; Chitosan; Drug Carriers; Drug Liberation; Ear; Imiquimod; Immunosuppressive Agents; Mice, Inbred C57BL; Nanoparticles; Particle Size; Psoriasis; Rats, Sprague-Dawley; Skin; Tacrolimus

2021
Tumor immunotherapy boosted by R837 nanocrystals through combining chemotherapy and mild hyperthermia.
    Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 350

    Topics: Cell Line, Tumor; Chitosan; Humans; Hydrogels; Hyperthermia, Induced; Imiquimod; Immunotherapy; Melanoma; Nanoparticles

2022
Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis.
    Environmental research, 2023, 10-01, Volume: 234

    Topics: Chitosan; Gallic Acid; Humans; Imiquimod; Lecithins; Nanoparticles; Particle Size; Psoriasis

2023
Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Animals; Cell Proliferation; Chitosan; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Interleukin-17; Interleukin-6; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2023